Trademark Overview
On Friday, July 9, 2004, a trademark application was filed for ANCELEX with the United States Patent and Trademark Office. The USPTO has given the ANCELEX trademark a serial number of 78448445. The federal status of this trademark filing is ABANDONED - EXPRESS as of Sunday, November 28, 2004. This trademark is owned by Biomarin Pharmaceutical Inc.. The ANCELEX trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:
Assays, screening kits, devices, and equipment for scientific analysis and diagnosis of disorders and physiological processes; assays, screening kits, devices, and equipment for measurement of disease markers for scientific purposes
Pharmaceutical preparations for use in enzyme therapy; pharmaceutical preparations for use in burn and wound debridement or cleaning; pharmaceutical preparations for treatment of inflammation, infectious diseases, cancer, lysosomal storage diseases, mucopolysaccharidoses, enzyme disorders, infections, respiratory diseases, pain, fever, cough, colds, skin diseases, and allergies; pharmaceutical preparations for treatment of endocrine, rheumatic, collagen, dermatologic, opthalmic, hematologic, euplastic, neoplastic, cardiovascular, gastrointestinal, neurological, metabolic, and genetic diseases and disorders; enzymes for use in disease treatment; enzymes for use in the treatment of fungal infections; proteins and enzymes for the production, purification and isolation of biologics for use in the treatment of medical conditions; biologics produced by recombinant DNA technology for use in the treatment of medical conditions; assays, screening kits, devices, and equipment for medical anaylsi...